Masha Paule Nathalie Strømme
Directeur/Membre du Conseil chez EXACT THERAPEUTICS
Fortune : 2 M $ au 30/04/2024
Postes actifs de Masha Paule Nathalie Strømme
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| EXACT THERAPEUTICS | Directeur/Membre du Conseil | 08/06/2022 | - |
| Président | 22/06/2018 | 08/06/2022 | |
Fortuna Fix, Inc.
 Fortuna Fix, Inc. BiotechnologyHealth Technology Fortuna Fix, Inc. operates as a clinical-stage regenerative medicine firm. It develops a patented direct cell reprogramming technology platform (drNPC) and a proprietary bio-scaffolding technology (RMx), for the treatment of neurodegenerative diseases and neurotrauma. The company is headquartered in Laval, Canada. | Directeur/Membre du Conseil | - | - |
| Fondateur | - | - | |
| Corporate Officer/Principal | - | - | |
Hemispherian AS
 Hemispherian AS Miscellaneous Commercial ServicesCommercial Services Hemispherian AS is a Norwegian company that focuses on epigenetic cancer therapeutics. The company is based in Oslo, Norway. The company's research and state-of-the-art technologies aim to transform cancer care and improve patient outcomes. The CEO of the company is Zeno Albisser. | Directeur/Membre du Conseil | - | - |
| PAACS Invest AS | Président | 01/09/2015 | - |
Historique de carrière de Masha Paule Nathalie Strømme
Anciens postes connus de Masha Paule Nathalie Strømme
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| NAVAMEDIC ASA | Directeur/Membre du Conseil | 18/06/2010 | 30/10/2015 |
| AQUA BIO TECHNOLOGY ASA | Directeur/Membre du Conseil | 05/07/2011 | 14/06/2012 |
Pharmasum Therapeutics AS
 Pharmasum Therapeutics AS BiotechnologyHealth Technology Pharmasum Therapeutics AS operates as a pharmaceutical company. The firm focuses on the discovery and development of novel human medicines for the treatment of brain diseases, especially neurological diseases. The company was founded by Anders Fugelli and John Sigurd Svendsen is headquartered in Kvaloysletta, Norway. | Directeur/Membre du Conseil | - | - |
| ARCTICZYMES TECHNOLOGIES ASA | Directeur/Membre du Conseil | - | - |
Formation de Masha Paule Nathalie Strømme
| University of Oxford | Doctorate Degree |
Statistiques
Internationale
| Norvège | 8 |
| Royaume-Uni | 2 |
| Canada | 2 |
Opérationnelle
| Director/Board Member | 7 |
| Chairman | 2 |
| Doctorate Degree | 1 |
Sectorielle
| Health Technology | 5 |
| Process Industries | 2 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| AQUA BIO TECHNOLOGY ASA | Process Industries |
| ARCTICZYMES TECHNOLOGIES ASA | Health Technology |
| NAVAMEDIC ASA | Distribution Services |
| EXACT THERAPEUTICS | Health Technology |
| Entreprise privées | 4 |
|---|---|
| PAACS Invest AS | |
Fortuna Fix, Inc.
Fortuna Fix, Inc. BiotechnologyHealth Technology Fortuna Fix, Inc. operates as a clinical-stage regenerative medicine firm. It develops a patented direct cell reprogramming technology platform (drNPC) and a proprietary bio-scaffolding technology (RMx), for the treatment of neurodegenerative diseases and neurotrauma. The company is headquartered in Laval, Canada. | Health Technology |
Pharmasum Therapeutics AS
Pharmasum Therapeutics AS BiotechnologyHealth Technology Pharmasum Therapeutics AS operates as a pharmaceutical company. The firm focuses on the discovery and development of novel human medicines for the treatment of brain diseases, especially neurological diseases. The company was founded by Anders Fugelli and John Sigurd Svendsen is headquartered in Kvaloysletta, Norway. | Health Technology |
Hemispherian AS
Hemispherian AS Miscellaneous Commercial ServicesCommercial Services Hemispherian AS is a Norwegian company that focuses on epigenetic cancer therapeutics. The company is based in Oslo, Norway. The company's research and state-of-the-art technologies aim to transform cancer care and improve patient outcomes. The CEO of the company is Zeno Albisser. | Commercial Services |
